F. Lastiri

发表

CBeV (cyclophosphamide, bendamustine and etoposide) pre-autotransplant conditioning in persons with lymphoma

R. Gale, P. Duarte, Gregorio Jaimovich, 2019, Bone Marrow Transplantation.

Autologous stem cell transplantation for patients with chronic myeloid leukemia

B. Koziner, G. Milone, C. Canepa, 2002, Cancer.

Randomized trial of CVPP for three versus six cycles in favorable-prognosis and CVPP versus AOPE plus radiotherapy in intermediate-prognosis untreated Hodgkin's disease.

C. Corrado, A. Rosso, E. Raslawski, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment strategy and long-term results in pediatric patients treated in two consecutive AML-GATLA trials

M. Felice, E. Dibar, F. Lastiri, 2005, Leukemia.

Multivariate analyses of prognostic factors associated with hematopoietic recovery in autograft patients with different sources of progenitor cells. A GATMO experience. Argintine Group of Bone Marrow Transplant.

C. Corrado, L. Feldman, B. Koziner, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.

Mike Clarke, K Wheatley, A Riccardi, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular monitoring of imatinib in chronic myeloid leukemia patients in complete cytogenetic remission: does achievement of a stable major molecular response at any time point identify a privileged group of patients? A multicenter experience in Argentina and Uruguay.

Juan F. García, R. Bengió, M. Pavlovsky, 2011, Clinical lymphoma, myeloma & leukemia.

Autologous Bone Marrow Transplantation Versus Chemotherapy in Acute Myeloblastic Leukemia Patients: Argentinean Study Results

B. Koziner, E. Bullorsky, S. Pavlovsky, 1997 .

Risk-adapted therapy with three or six cycles of doxorubicin/bleomycin/vinblastine/dacarbazine plus involved-field radiation therapy in Hodgkin lymphoma, based on prognosis at diagnosis and early response: results from the GATLA study.

C. Corrado, R. Bezares, M. Pavlovsky, 2010, Clinical lymphoma, myeloma & leukemia.

Progress in the prognosis of adult Hodgkin's lymphoma in the past 35 years through clinical trials in Argentina: a GATLA experience.

S. Pavlovsky, F. Lastiri, 2004, Clinical lymphoma.

Berg Balance Scale: inter-rater and intra-rater reliability of the Spanish version with incomplete spinal cord injured subjects

F. Lastiri, M. Elizalde, O. Freixes, 2020, Spinal Cord Series and Cases.

A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients.

M. Vilanova, E. Cazap, G. Recondo, 2001, European journal of cancer.

CBeV (cyclophosphamide, bendamustine and etoposide) pre-autotransplant conditioning in persons with lymphoma

R. Gale, P. Duarte, Gregorio Jaimovich, 2019, Bone Marrow Transplantation.

Pediatric Hodgkin Lymphoma through Clinical Trials in Argentina in the Past 46 Years: The GATLA Experience

E. Schvartzman, S. Pavlovsky, D. Verón, 2014 .